264 related articles for article (PubMed ID: 37537209)
1. Patient-derived tumor models: a suitable tool for preclinical studies on esophageal cancer.
Liang F; Xu H; Cheng H; Zhao Y; Zhang J
Cancer Gene Ther; 2023 Nov; 30(11):1443-1455. PubMed ID: 37537209
[TBL] [Abstract][Full Text] [Related]
2. Tumor xenograft animal models for esophageal squamous cell carcinoma.
Lee NP; Chan CM; Tung LN; Wang HK; Law S
J Biomed Sci; 2018 Aug; 25(1):66. PubMed ID: 30157855
[TBL] [Abstract][Full Text] [Related]
3. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of esophageal squamous cell carcinoma patient-derived xenograft mouse models for preclinical drug discovery.
Zhang J; Jiang D; Li X; Lv J; Xie L; Zheng L; Gavine PR; Hu Q; Shi Y; Tan L; Ge D; Xu S; Li L; Zhu L; Hou Y; Wang Q
Lab Invest; 2014 Aug; 94(8):917-26. PubMed ID: 24999713
[TBL] [Abstract][Full Text] [Related]
5. Imaging of Secreted Extracellular Periostin, an Important Marker of Invasion in the Tumor Microenvironment in Esophageal Cancer.
Heidari P; Esfahani SA; Turker NS; Wong G; Wang TC; Rustgi AK; Mahmood U
J Nucl Med; 2015 Aug; 56(8):1246-51. PubMed ID: 26069303
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers.
Lan T; Xue X; Dunmall LC; Miao J; Wang Y
Aging (Albany NY); 2021 Apr; 13(8):12273-12293. PubMed ID: 33903283
[TBL] [Abstract][Full Text] [Related]
7. A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.
Veeranki OL; Tong Z; Mejia A; Verma A; Katkhuda R; Bassett R; Kim TB; Wang J; Lang W; Mino B; Solis L; Kingsley C; Norton W; Tailor R; Wu JY; Krishnan S; Lin SH; Blum M; Hofstetter W; Ajani J; Kopetz S; Maru D
Dis Model Mech; 2019 Dec; 12(12):. PubMed ID: 31732509
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma.
Kauppila JH; Wahlin K; Lagergren P; Lagergren J
Int J Cancer; 2019 Mar; 144(6):1284-1291. PubMed ID: 30168595
[TBL] [Abstract][Full Text] [Related]
9. Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models.
Wu X; Zhang J; Zhen R; Lv J; Zheng L; Su X; Zhu G; Gavine PR; Xu S; Lu S; Hou J; Liu Y; Xu C; Tan Y; Xie L; Yin X; He D; Ji Q; Hou Y; Ge D
J Transl Med; 2012 Aug; 10():180. PubMed ID: 22935382
[TBL] [Abstract][Full Text] [Related]
10. Chemokines and their receptors as biomarkers in esophageal cancer.
Goto M; Liu M
Esophagus; 2020 Apr; 17(2):113-121. PubMed ID: 31773415
[TBL] [Abstract][Full Text] [Related]
11. Understanding the cellular origin and progression of esophageal cancer using esophageal organoids.
Sachdeva UM; Shimonosono M; Flashner S; Cruz-Acuña R; Gabre JT; Nakagawa H
Cancer Lett; 2021 Jul; 509():39-52. PubMed ID: 33838281
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of B-NDG
Guan L; Zou Q; Liu Q; Chen S
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Aug; 40(8):1200-1206. PubMed ID: 32895183
[TBL] [Abstract][Full Text] [Related]
13. Patient-Derived Xenograft and Mice Models in Esophageal Squamous Cell Carcinoma.
Lam AK; Tang JC
Methods Mol Biol; 2020; 2129():137-147. PubMed ID: 32056175
[TBL] [Abstract][Full Text] [Related]
14. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
[TBL] [Abstract][Full Text] [Related]
15. Preclinical Study of Novel Curcumin Analogue SSC-5 Using Orthotopic Tumor Xenograft Model for Esophageal Squamous Cell Carcinoma.
Tung LN; Song S; Chan KT; Choi MY; Lam HY; Chan CM; Chen Z; Wang HK; Leung HT; Law S; Huang Y; Song H; Lee NP
Cancer Res Treat; 2018 Oct; 50(4):1362-1377. PubMed ID: 29361818
[TBL] [Abstract][Full Text] [Related]
16. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer.
Liu K; Zhao T; Wang J; Chen Y; Zhang R; Lan X; Que J
Cancer Lett; 2019 Aug; 458():21-28. PubMed ID: 31125642
[TBL] [Abstract][Full Text] [Related]
17. The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients.
Strizova Z; Snajdauf M; Stakheev D; Taborska P; Vachtenheim J; Biskup J; Lischke R; Bartunkova J; Smrz D
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1979-1992. PubMed ID: 32447483
[TBL] [Abstract][Full Text] [Related]
18. Roles of Nuclear Receptors in Esophageal Cancer.
Deng L; Liu J; Chen WD; Wang YD
Curr Pharm Biotechnol; 2023; 24(12):1489-1503. PubMed ID: 36740804
[TBL] [Abstract][Full Text] [Related]
19. Prognostic evaluation of esophageal cancer patients with stages I-III.
Qiu MJ; Yang SL; Wang MM; Li YN; Jiang X; Huang ZZ; Xiong ZF
Aging (Albany NY); 2020 Jul; 12(14):14736-14753. PubMed ID: 32701062
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in treating oesophageal cancer.
Harada K; Rogers JE; Iwatsuki M; Yamashita K; Baba H; Ajani JA
F1000Res; 2020; 9():. PubMed ID: 33042518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
